Interleukin-2 after T-cell-depleted allogeneic bone marrow transplantation.
Salgado
C
C
Urbano-Ispizua
A
A
Rozman
C
C
Sierra
J
J
Carreras
E
E
Montserrat
E
E
D000328:Adult; D016026:Bone Marrow Transplantation; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007279:Injections, Subcutaneous; D007376:Interleukin-2 / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000187:drug effects*; D007938:Leukemia / Q000628:therapy*; D008212:Lymphocyte Depletion; D008297:Male; D008875:Middle Aged; D018365:Neoplasm, Residual; D013601:T-Lymphocytes
D007155:Immunologic Factors; D007376:Interleukin-2